Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment.

Sugiyama, T

Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment. [electronic resource] - Gene therapy Mar 2013 - 338-47 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1476-5462

10.1038/gt.2012.44 doi


Animals
Antigens, CD--genetics
Breast Neoplasms--genetics
CHO Cells
Cell Adhesion Molecules--genetics
Cell Line
Cell Line, Tumor
Chlorocebus aethiops
Cricetinae
Cricetulus
Female
HEK293 Cells
Humans
MCF-7 Cells
Macaca fascicularis
Macaca mulatta
Measles virus--genetics
Membrane Cofactor Protein--genetics
Mice
Mice, Inbred BALB C
Mice, Nude
Oncolytic Virotherapy--methods
Oncolytic Viruses--genetics
Receptors, Cell Surface--genetics
Signaling Lymphocytic Activation Molecule Family Member 1
Vero Cells
Xenograft Model Antitumor Assays